Project Grant H79TI088539
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA) awarded Mennonite General Hospital, Inc. (MGHPR) $11,407,500 on September 30, 2025, under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) to deliver integrated hepatitis C screening, testing, and rapid treatment across Puerto Rico. Over three years, the HEP C FREE Puerto Rico Integrated Care Pilot will screen 10,000...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded $1.125 million to Centro Deambulantes Cristo Pobre Inc. on September 30, 2025, under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243). Centro Deambulantes Cristo Pobre, a nonprofit organization located in Ponce, Puerto Rico, will deliver an ambulatory-based recovery program for adults aged 18 and older experiencing...
- The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded Intercambios Puerto Rico, Inc., $2.25 million on September 30, 2025, under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) to expand treatment and harm reduction capacity in eastern Puerto Rico. Intercambios Puerto Rico will screen individuals for substance use disorder (SUD) and co-occurring disorder (COD) and risk for suicide; provide SUD and COD...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded $1.5 million to Administracion De Servicios De Salud Mental Y Contra La Adiccion (Assmca) on September 30, 2026, under the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances program (CFDA 93.104). The Puerto Rico Children's Mental Health Initiative will establish a family-driven, youth-guided system of care in Vega Alta and Maunabo, Puerto...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded $66.208 million to Administración de Servicios de Salud Mental y Contra la Adicción (Assmca) on October 1, 2025, under the Substance Use Prevention, Treatment, and Recovery Services Block Grant (CFDA 93.959). The award supports substance abuse prevention, treatment, and recovery services delivered across Puerto Rico through October 1, 2027. Assmca, Puerto Rico's designated territorial...
- The Substance Abuse and Mental Health Services Administration awarded $28.313 million to Administracion De Servicios De Salud Mental Y Contra La Adiccion (Assmca) under the Block Grants for Community Mental Health Services program (CFDA 93.958) on October 1, 2025. The award funds comprehensive community mental health services delivered to adults with serious mental illness and children with serious emotional disturbance across Puerto Rico. Assmca, Puerto Rico's designated state-level...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded Guara Bi Inc. $2.25 million on September 30, 2025, under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243). Guara Bi, in partnership with Corporacion Sanos, Inc., will expand access to substance use disorder and co-occurring disorder treatment and recovery support services in Barceloneta and Arecibo, Puerto Rico, regions...
- The federal Block Grant award of $778,453.00 was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Block Grants for Community Mental Health Services program (CFDA 93.958). The award, with a period of performance from Sep 30, 2024 to Sep 29, 2026, supports the Administracion De Servicios De Salud Mental Y Contra La Adiccion (ASSMCA) in Puerto Rico to deliver comprehensive community mental health services to adults with serious mental illness and children...
- The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded La Maestra Family Clinic, Inc., $545,000 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to expand evidence-based substance use disorder and co-occurring disorder treatment services for youth and young adults ages 12–25 in San Diego County. La Maestra, a federally qualified health center and San Diego-based nonprofit, will...
- The Substance Abuse and Mental Health Services Administration awarded Hackensack University Medical Center $995,000 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to expand Screening, Brief Intervention and Referral to Treatment (SBIRT) services throughout Monmouth and Ocean Counties, New Jersey. The project will serve 2,000 youth in year one and 22,000 youth over the five-year performance period ending...
The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded Mennonite General Hospital, Inc. $995,000 on September 30, 2026, under the Center for Substance Abuse Treatment Projects of Regional and National Significance program (CFDA 93.490) to implement a system-wide screening and brief intervention initiative for substance use across Puerto Rico. The recipient, operating through its Centro De Salud Conductual Menonita Cima behavioral health division, will deploy universal screening, motivational interviewing, and evidence-based brief intervention protocols (Teen Intervene, A-CRA, FRAMES) across 21 Mennonite General Hospital sites serving 27 municipalities across Puerto Rico with a population catchment of 957,077. The project targets youth ages 12–21 with chronic or complex health conditions, individuals at risk for or experiencing substance use disorders, and those with co-occurring behavioral health conditions. Services include care coordination, telehealth, warm handoffs, peer recovery support, and family engagement. The initiative will serve 200 individuals in year one and 2,200 over the five-year period of performance, which runs through September 29, 2031. Performance objectives include screening at least 80 percent of eligible patients, delivering brief interventions to 85 percent of positive screens, achieving 75 percent treatment engagement, and maintaining 80 percent six-month follow-up rates.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $995.0k | 8/28/26 |